In the present study, the combination of albumin and D-dimer, as compared to albumin and D-dimer alone, enabled ADR to be an improved predictor of survival outcome in advanced GC patients, demonstrating that decreased albumin and increased D-dimer levels simultaneously reflect the nature of the disease. The gene discussed is ALB; the disease is gastric cancer.